Shanghai Fosun Pharmaceutical Group Co Ltd (600196) — Free Cash Flow Generation Index
Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a Free Cash Flow Generation Index of 0.47x as of December 2025. Free cash flow of CN¥1.12 Billion represents 0% of operating cash flow (CN¥2.40 Billion). Explore 600196 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shanghai Fosun Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (1998–2025)
Historical FCF Generation Index trend for Shanghai Fosun Pharmaceutical Group Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Shanghai Fosun Pharmaceutical Group Co L.
Annual Free Cash Flow Generation for Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year Free Cash Flow Generation Index for Shanghai Fosun Pharmaceutical Group Co Ltd. Check 600196 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.26x | CN¥1.56 Billion | CN¥6.01 Billion | CN¥4.45 Billion | ▲ +1637.7% |
| 2024 | 0.01x | CN¥66.79 Million | CN¥4.48 Billion | CN¥4.41 Billion | ▲ +103.4% |
| 2023 | -0.44x | CN¥-1.92 Billion | CN¥4.36 Billion | CN¥5.34 Billion | ▼ -11.2% |
| 2022 | -0.40x | CN¥-1.67 Billion | CN¥4.22 Billion | CN¥5.89 Billion | ▼ -52.8% |
| 2021 | -0.26x | CN¥-1.02 Billion | CN¥3.95 Billion | CN¥4.97 Billion | ▲ +64.0% |
| 2020 | -0.72x | CN¥-1.86 Billion | CN¥2.58 Billion | CN¥4.44 Billion | ▼ -213.7% |
| 2019 | -0.23x | CN¥-739.65 Million | CN¥3.22 Billion | CN¥3.96 Billion | ▼ -201.2% |
| 2018 | -0.08x | CN¥-224.81 Million | CN¥2.95 Billion | CN¥3.17 Billion | ▼ -148.0% |
| 2017 | 0.16x | CN¥409.61 Million | CN¥2.58 Billion | CN¥2.17 Billion | ▲ +78.1% |
| 2016 | 0.09x | CN¥188.08 Million | CN¥2.11 Billion | CN¥1.92 Billion | ▼ -62.5% |
| 2015 | 0.24x | CN¥385.49 Million | CN¥1.62 Billion | CN¥1.24 Billion | ▲ +253.3% |
| 2014 | 0.07x | CN¥80.78 Million | CN¥1.20 Billion | CN¥1.12 Billion | ▲ +339.6% |
| 2013 | -0.03x | CN¥-28.42 Million | CN¥1.01 Billion | CN¥1.04 Billion | ▲ +96.2% |
| 2012 | -0.74x | CN¥-495.08 Million | CN¥665.52 Million | CN¥1.16 Billion | ▲ +50.9% |
| 2011 | -1.52x | CN¥-480.18 Million | CN¥316.65 Million | CN¥796.83 Million | ▼ -127.1% |
| 2010 | -0.67x | CN¥-135.81 Million | CN¥203.36 Million | CN¥339.17 Million | ▼ -102.9% |
| 2009 | -0.33x | CN¥-86.20 Million | CN¥261.87 Million | CN¥348.07 Million | ▼ -442.3% |
| 2008 | 0.10x | CN¥22.41 Million | CN¥233.04 Million | CN¥210.63 Million | ▲ +116.2% |
| 2007 | -0.59x | CN¥-78.23 Million | CN¥131.48 Million | CN¥209.71 Million | ▼ -34.7% |
| 2006 | -0.44x | CN¥-81.69 Million | CN¥184.91 Million | CN¥266.61 Million | ▼ -142.9% |
| 2005 | -0.18x | CN¥-34.26 Million | CN¥188.35 Million | CN¥222.60 Million | ▼ -43884.5% |
| 2004 | 0.00x | CN¥85.20K | CN¥205.10 Million | CN¥205.02 Million | ▲ +100.1% |
| 2003 | -0.76x | CN¥-113.92 Million | CN¥150.14 Million | CN¥264.05 Million | ▼ -109.9% |
| 2002 | -0.36x | CN¥-37.05 Million | CN¥102.47 Million | CN¥139.52 Million | ▲ +66.4% |
| 2001 | -1.08x | CN¥-73.35 Million | CN¥68.15 Million | CN¥141.51 Million | ▼ -1362.5% |
| 2000 | 0.09x | CN¥11.80 Million | CN¥138.43 Million | CN¥126.63 Million | ▲ +108.2% |
| 1999 | -1.04x | CN¥-39.79 Million | CN¥38.20 Million | CN¥77.99 Million | ▼ -584.7% |
| 1998 | 0.21x | CN¥14.30 Million | CN¥66.55 Million | CN¥52.25 Million | — |